Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection (Q42166261)
Jump to navigation
Jump to search
scientific article published on October 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection |
scientific article published on October 2003 |
Statements
1 reference
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection (English)
1 reference
Gregory Y H Lip
1 reference
Andrew D Blann
1 reference
Bernard S P Chin
1 reference
Christopher R Gibbs
1 reference
1 October 2003
1 reference
1 reference
Identifiers
1 reference